eMultiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, ...
Cognitive impairment is increasingly recognized in patients with cerebral venous congestion (CVC), yet the cognitive tools used are largely adapted from stroke and dementia research. This review ...
22 Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Berlin, ...
Introduction Combination of the noradrenergic atomoxetine with either the antimuscarinic aroxybutynin or trazodone has been shown to improve obstructive sleep apnoea (OSA) severity. However, ...
PTC Therapeutics is a commercial stage biotechnology firm. Its last Phase 2 trial, investigating PTC518 in Huntington's disease, released mixed results about the drug efficacy. We think a Phase 3 ...
The following is a summary of “Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND cognition substudy,” published in the April 2025 issue of Journal of Neurology by ...
Credit: Getty Images In an interim analysis of ENLIGHTEN, researchers described changes in cognitive function over 1 year in patients with MS. For the Symbol Digit Modalities Test, clinically ...
The Floodlight MS app, a digital health application used to track dexterity, walking function, and cognition in people with multiple sclerosis (MS), has been deemed cost-effective in a new analysis.
Please provide your email address to receive an email when new articles are posted on . Prolonged REM sleep latency was associated with three key Alzheimer’s-specific pathological changes. REM sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback